These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2673124)

  • 1. [Infection studies in laboratory mice with erysipelas and coli bacteria after the administration of biotechnical substances].
    Lusky K; Bache K; Rimke H; Zwies G
    Arch Exp Veterinarmed; 1989 Jan; 43(1):129-36. PubMed ID: 2673124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The fertility performance (litter characteristics) of laboratory mice over 6 generations after the administration of chlormadinone acetate and human chorionic gonadotropin].
    Lusky K; Bache K; Zwies G
    Arch Exp Veterinarmed; 1989 Jan; 43(1):137-46. PubMed ID: 2476101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Animal experiment studies on the modification of non-pathogen specific immunity by metabolic products of Escherichia coli].
    Müller E; Sonnenschein B; Petzoldt K
    Zentralbl Veterinarmed B; 1985 Dec; 32(10):744-50. PubMed ID: 3913254
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gentamicin and experimental immunosuppression].
    Hatala M; Liska M; Vrubel J; Málek P
    Cas Lek Cesk; 1970 Apr; 109(17):381-4. PubMed ID: 4910129
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental Escherichia coli 06 infection in mice. II. Protective factors of immunity after immunosuppression.
    Ahlstedt S
    Scand J Infect Dis Suppl; 1980; Suppl 24():216-9. PubMed ID: 7010558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of a protective immunity in mice against Escherichia coli by phenothiazines, 10-[n-(phthalimido)alkyl]-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazines-10-yl)alkyl-1 -ureas .
    Komatsu N; Motohashi N; Fujimaki M; Molnár J
    In Vivo; 1997; 11(1):13-6. PubMed ID: 9067767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infant mouse model of E. coli diarrhoea: clinical protection induced by vaccination of the mothers.
    Duchet-Suchaux M
    Ann Rech Vet; 1983; 14(3):319-31. PubMed ID: 6362544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laboratory studies of the possibility of oral immunization with a sodium desoxycholate extract of dyspepsia coli strains. VII. Serum antibodies in the indirect hemagglutination reaction in immunized and loaded mice].
    Mochmann H; Ocklitz HW; Schmidt EF; Richter U; Hering L
    Zentralbl Bakteriol Orig; 1968; 208(1):58-69. PubMed ID: 4915132
    [No Abstract]   [Full Text] [Related]  

  • 9. Batch potency testing of inactivated erysipelas vaccines by ELISA--development, validation and implementation.
    Rosskopf-Streicher U; Johannes S; Gyra H; Beckmann R; Cussler K
    Dev Biol (Basel); 2002; 111():153-8. PubMed ID: 12678235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of antineoplastic antibiotics on resistance to bacterial infections of animals with transplanted lymphadenosis NK-LI].
    Shapovalova SP
    Antibiotiki; 1972 Apr; 17(4):339-43. PubMed ID: 4559319
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological approach to the pathogenetical role of Escherichia coli adhesive factor "119" in a suckling mouse urinary tract model.
    Kétyi I
    Acta Microbiol Acad Sci Hung; 1982; 29(2):123-7. PubMed ID: 6127911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection.
    Colino J; Outschoorn I
    Microb Pathog; 1999 Oct; 27(4):187-96. PubMed ID: 10502459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental Escherichia coli 06 infection in mice. IV. On the relative importance of complement factors and antibodies for the host defence.
    Ahlstedt S
    Acta Pathol Microbiol Scand C; 1981 Feb; 89(1):23-8. PubMed ID: 7027735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of the immunomodulating action of bacterial and non-bacterial products].
    Ghione M
    G Ital Chemioter; 1985; 32(1):141-5. PubMed ID: 3830771
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacteria-immune system interactions. X. Effects of aging on Balb/c mice response to Escherichia coli.
    Kleinman R; Lewis JA
    Prog Clin Biol Res; 1983; 133():95-9. PubMed ID: 6353422
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphological and immune response alterations in the intestinal mucosa of the mouse after short periods on a low-magnesium diet.
    Zimowska W; Girardeau JP; Kuryszko J; Bayle D; Rayssiguier Y; Mazur A
    Br J Nutr; 2002 Nov; 88(5):515-22. PubMed ID: 12425732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice.
    Gagnon M; Kheadr EE; Dabour N; Richard D; Fliss I
    Int J Food Microbiol; 2006 Aug; 111(1):26-33. PubMed ID: 16822570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Passive immunization trials against the infection with E. coli 0101:K30 strain, pathogenic to newborn mice].
    Kétyi I
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):235-41. PubMed ID: 4869921
    [No Abstract]   [Full Text] [Related]  

  • 19. Prior infection of Manduca sexta with non-pathogenic Escherichia coli elicits immunity to pathogenic Photorhabdus luminescens: roles of immune-related proteins shown by RNA interference.
    Eleftherianos I; Marokhazi J; Millichap PJ; Hodgkinson AJ; Sriboonlert A; ffrench-Constant RH; Reynolds SE
    Insect Biochem Mol Biol; 2006 Jun; 36(6):517-25. PubMed ID: 16731347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental infection and immunity of enteroinvasive Escherichia coli in the cornea of guinea pigs].
    Yang ZS; Huang NJ
    Wei Sheng Wu Xue Bao; 1987 Sep; 27(3):284-9. PubMed ID: 3326283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.